Ikena Oncology, Inc. (NASDAQ:IKNA – Free Report) – Equities research analysts at HC Wainwright issued their Q2 2024 earnings per share estimates for shares of Ikena Oncology in a note issued to investors on Thursday, November 9th. HC Wainwright analyst A. Maldonado expects that the company will post earnings of ($0.44) per share for the […]
Related Keywords
United States , , Dimensional Fund Advisors , Charles Schwab Investment Management Inc , Blackrock Inc , Nasdaq , Barclays Plc , Ikena Oncology Company Profile , Jpmorgan Chase Co , Ikena Oncology Inc , Ikena Oncology , Free Report , Oncology Stock Down , Schwab Investment Management , Fund Advisors , Get Free Report , Ikena Oncology Daily , Nasdaq Ikna , Vikna , Medical , Earnings Estimates , Hc Wainwright ,
comparemela.com © 2020. All Rights Reserved.